June 8th 1pm EDT Webinar Hosted by CEO David Regan & CSO Len Pagliaro PhD

Play Video

Live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO in which they discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.


Subscribe to Our Newsletter

Download the Company Presentation

Read or Download the Latest White Paper

The Case for Hyperthermia Thermal Therapy for Cancer - White Paper - Sona Nanotech

The Case for “Hyperthermia” Thermal Therapy for Cancer